265 related articles for article (PubMed ID: 22659408)
1. Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate (NAAG).
Romei C; Raiteri M; Raiteri L
Neuropharmacology; 2013 Mar; 66():311-6. PubMed ID: 22659408
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic mGlu7 receptors control GABA release in mouse hippocampus.
Summa M; Di Prisco S; Grilli M; Usai C; Marchi M; Pittaluga A
Neuropharmacology; 2013 Mar; 66():215-24. PubMed ID: 22564442
[TBL] [Abstract][Full Text] [Related]
3. Group II metabotropic glutamate receptors inhibit glutamate release at thalamocortical synapses in the developing somatosensory cortex.
Mateo Z; Porter JT
Neuroscience; 2007 May; 146(3):1062-72. PubMed ID: 17418955
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic inhibition of corticothalamic feedback by metabotropic glutamate receptors.
Alexander GM; Godwin DW
J Neurophysiol; 2005 Jul; 94(1):163-75. PubMed ID: 15772234
[TBL] [Abstract][Full Text] [Related]
5. beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor.
Lea PM; Wroblewska B; Sarvey JM; Neale JH
J Neurophysiol; 2001 Mar; 85(3):1097-106. PubMed ID: 11247980
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with mGluR2 or mGluR3 Agonists Reduces Apoptosis Induced by Hypoxia-Ischemia in Neonatal Rat Brains.
Bratek-Gerej E; Bronisz A; Ziembowicz A; Salinska E
Oxid Med Cell Longev; 2021; 2021():8848015. PubMed ID: 33763176
[TBL] [Abstract][Full Text] [Related]
7. Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR.
Fricker AC; Mok MH; de la Flor R; Shah AJ; Woolley M; Dawson LA; Kew JN
Neuropharmacology; 2009; 56(6-7):1060-7. PubMed ID: 19285517
[TBL] [Abstract][Full Text] [Related]
8. 5-HT
Olivero G; Grilli M; Vergassola M; Bonfiglio T; Padolecchia C; Garrone B; Di Giorgio FP; Tongiani S; Usai C; Marchi M; Pittaluga A
Neuropharmacology; 2018 May; 133():429-439. PubMed ID: 29499271
[TBL] [Abstract][Full Text] [Related]
9. Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.
Di Liberto V; Bonomo A; Frinchi M; Belluardo N; Mudò G
Neuroscience; 2010 Feb; 165(3):863-73. PubMed ID: 19909793
[TBL] [Abstract][Full Text] [Related]
10. Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis.
Giribaldi F; Milanese M; Bonifacino T; Anna Rossi PI; Di Prisco S; Pittaluga A; Tacchetti C; Puliti A; Usai C; Bonanno G
Neuropharmacology; 2013 Mar; 66():253-63. PubMed ID: 22634363
[TBL] [Abstract][Full Text] [Related]
11. The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing.
Cartmell J; Monn JA; Schoepp DD
Eur J Pharmacol; 2000 Jul; 400(2-3):221-4. PubMed ID: 10988337
[TBL] [Abstract][Full Text] [Related]
12. Amygdala group II mGluRs mediate the inhibitory effects of systemic group II mGluR activation on behavior and spinal neurons in a rat model of arthritis pain.
Mazzitelli M; Neugebauer V
Neuropharmacology; 2019 Nov; 158():107706. PubMed ID: 31306647
[TBL] [Abstract][Full Text] [Related]
13. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism.
Xi ZX; Li X; Peng XQ; Li J; Chun L; Gardner EL; Thomas AG; Slusher BS; Ashby CR
J Neurochem; 2010 Jan; 112(2):564-76. PubMed ID: 19895667
[TBL] [Abstract][Full Text] [Related]
15. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
Hicks C; Gregg RA; Nayak SU; Cannella LA; Schena GJ; Tallarida CS; Reitz AB; Smith GR; Rawls SM
Psychopharmacology (Berl); 2017 Jun; 234(11):1671-1681. PubMed ID: 28251297
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological evidence of functional inhibitory metabotrophic glutamate receptors on mouse arousal-related cholinergic laterodorsal tegmental neurons.
Kohlmeier KA; Christensen MH; Kristensen MP; Kristiansen U
Neuropharmacology; 2013 Mar; 66():99-113. PubMed ID: 22381584
[TBL] [Abstract][Full Text] [Related]
17. Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex.
Kiritoshi T; Neugebauer V
Neuropharmacology; 2015 Aug; 95():388-94. PubMed ID: 25912637
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
[TBL] [Abstract][Full Text] [Related]
19. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells.
Wroblewska B; Wroblewski JT; Pshenichkin S; Surin A; Sullivan SE; Neale JH
J Neurochem; 1997 Jul; 69(1):174-81. PubMed ID: 9202308
[TBL] [Abstract][Full Text] [Related]
20. NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance.
Zhao J; Ramadan E; Cappiello M; Wroblewska B; Bzdega T; Neale JH
Eur J Neurosci; 2001 Jan; 13(2):340-6. PubMed ID: 11168538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]